米国有害事象自発報告（FAERS）を用いたアスピリンおよび併用薬の消化管傷害に関する解析

DOI
  • 細見 光一
    近畿大学薬学部臨床薬学部門臨床薬剤情報学分野
  • 藤本 麻依
    近畿大学薬学部臨床薬学部門臨床薬剤情報学分野
  • 八軒 浩子
    近畿大学薬学部臨床薬学部門臨床薬剤情報学分野
  • 炭床 啓太
    近畿大学薬学部臨床薬学部門臨床薬剤情報学分野
  • 高田 充隆
    近畿大学薬学部臨床薬学部門臨床薬剤情報学分野

書誌事項

タイトル別名
  • Gastrointestinal tract injury Associated with Aspirin and Other Drugs: Data Mining of the FDA Adverse Event Reporting System, FAERS

この論文をさがす

抄録

Objective: To examine the signal of gastrointestinal tract injury induced by aspirin and other drugs, we analyzed the US FDA Adverse Event Reporting System (FAERS).<br>Methods: After deleting duplicate submissions, we analyzed the reports involving gastrointestinal tract injury associated with aspirin, H2-receptor antagonists (H2RAs), proton pump inhibitors (PPIs), ACE inhibitors, angiotensin II receptor blockers (ARBs), and antiplatelet and antithrombotic drugs.  The reporting odds ratio (ROR), a recognized pharmacovigilance tool, was used for the quantitative detection of signals.<br>Results: Based on 29,017,485 co-occurrences, i.e., drug-adverse event pairs, found in 1,645,605 reports from 2004 to 2009, the ROR-associated gastrointestinal tract injury for aspirin alone, aspirin with H2RAs, aspirin with PPIs, aspirin with ACE inhibitors, aspirin with ARBs, and aspirin with antiplatelet and antithrombotic drugs were 2.88, 1.42, 1.46, 1.00, 1.05, and 2.98-8.26, respectively.  The following summarizes the types of listed reports: 86 reports described the daily aspirin doses, and 36/86 were between 75 and 100 mg; 343 reports described the periods between the start-date for aspirin and the date when gastrointestinal tract injury occurred, of which 128/343 were within one month while 215/343 were over one month; additionally, 78 reports described the total cumulative doses of aspirin, and 17/78 were between 1 and 5 g.<br>Conclusion: The data suggest that H2RAs, PPIs, ACE inhibitors, and ARBs may reduce gastrointestinal tract injury associated with aspirin in possibility.

収録刊行物

  • 医薬品情報学

    医薬品情報学 15 (4), 147-154, 2014

    一般社団法人　日本医薬品情報学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ